These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30868390)

  • 1. Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues.
    Delgado-López PD; Corrales-García EM; Alonso-García E; García-Leal R; González-Rodrigálvarez R; Araus-Galdós E; Martín-Alonso J
    Clin Transl Oncol; 2019 Nov; 21(11):1450-1463. PubMed ID: 30868390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma.
    Merchant TE; Bendel AE; Sabin ND; Burger PC; Shaw DW; Chang E; Wu S; Zhou T; Eisenstat DD; Foreman NK; Fuller CE; Anderson ET; Hukin J; Lau CC; Pollack IF; Laningham FH; Lustig RH; Armstrong FD; Handler MH; Williams-Hughes C; Kessel S; Kocak M; Ellison DW; Ramaswamy V
    J Clin Oncol; 2019 Apr; 37(12):974-983. PubMed ID: 30811284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
    Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
    Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.
    Pajtler KW; Witt H; Sill M; Jones DT; Hovestadt V; Kratochwil F; Wani K; Tatevossian R; Punchihewa C; Johann P; Reimand J; Warnatz HJ; Ryzhova M; Mack S; Ramaswamy V; Capper D; Schweizer L; Sieber L; Wittmann A; Huang Z; van Sluis P; Volckmann R; Koster J; Versteeg R; Fults D; Toledano H; Avigad S; Hoffman LM; Donson AM; Foreman N; Hewer E; Zitterbart K; Gilbert M; Armstrong TS; Gupta N; Allen JC; Karajannis MA; Zagzag D; Hasselblatt M; Kulozik AE; Witt O; Collins VP; von Hoff K; Rutkowski S; Pietsch T; Bader G; Yaspo ML; von Deimling A; Lichter P; Taylor MD; Gilbertson R; Ellison DW; Aldape K; Korshunov A; Kool M; Pfister SM
    Cancer Cell; 2015 May; 27(5):728-43. PubMed ID: 25965575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Ependymoma in Children, Adolescents and Young Adults.
    Thorp N; Gandola L
    Clin Oncol (R Coll Radiol); 2019 Mar; 31(3):162-170. PubMed ID: 30616927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current therapy and the evolving molecular landscape of paediatric ependymoma.
    Khatua S; Ramaswamy V; Bouffet E
    Eur J Cancer; 2017 Jan; 70():34-41. PubMed ID: 27866097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.
    Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S
    Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
    Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Billups CA; Bowers DC; Bendel AE; Hassall T; Crawford JR; Partap S; Fisher PG; Tatevossian RG; Seah T; Qaddoumi IA; Vinitsky A; Armstrong GT; Sabin ND; Tinkle CL; Klimo P; Indelicato DJ; Boop FA; Merchant TE; Ellison DW; Gajjar A
    Neuro Oncol; 2019 Oct; 21(10):1319-1330. PubMed ID: 30976811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Ependymoma.
    Vitanza NA; Partap S
    J Child Neurol; 2016 Oct; 31(12):1354-66. PubMed ID: 26503805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of childhood ependymoma.
    Merchant TE
    Oncology (Williston Park); 2002 May; 16(5):629-42, 644; discussion 645-6, 648. PubMed ID: 12108890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology.
    Gessi M; Giagnacovo M; Modena P; Elefante G; Gianno F; Buttarelli FR; Arcella A; Donofrio V; Diomedi Camassei F; Nozza P; Morra I; Massimino M; Pollo B; Giangaspero F; Antonelli M
    Am J Surg Pathol; 2019 Jan; 43(1):56-63. PubMed ID: 29266023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
    Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
    Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant Cell Ependymoma of Lateral Ventricle: Case Report, Literature Review, and Analysis of Prognostic Factors and Genetic Profile.
    Takami H; Graffeo CS; Perry A; Raghunathan A; Jenkins RB; Giannini C; Burns TC
    World Neurosurg; 2017 Dec; 108():997.e9-997.e14. PubMed ID: 28943417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric ependymomas: will molecular biology change patient management?
    Grill J; Bergthold G; Ferreira C
    Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
    Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
    Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ependymal tumors.
    Moynihan TJ
    Curr Treat Options Oncol; 2003 Dec; 4(6):517-23. PubMed ID: 14585232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of childhood ependymoma: a multitude of syndromes.
    Allen JC; Siffert J; Hukin J
    Pediatr Neurosurg; 1998 Jan; 28(1):49-55. PubMed ID: 9693331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups.
    Ritzmann TA; Rogers HA; Paine SML; Storer LCD; Jacques TS; Chapman RJ; Ellison D; Donson AM; Foreman NK; Grundy RG
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28426. PubMed ID: 32614133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.